Live Breaking News & Updates on Alphamab Oncology

Stay updated with breaking news from Alphamab oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CTLA-4 Inhibitors Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Mechanism Of Action, Route Of Administration, And Comp...

....

United States , Innovent Biologics , Bristol Myers Squibb , Akeso Biopharma , Drugs Under Different Phases Of Clinical Development , Pharmaceuticals Inc , Drug Administration , University Collaborations Licensing Partnering Analysis , Alpine Immune Sciences , Akeso Biopharma Co Ltd , Route Of Administration , Biocytogen Pharmaceuticals , Inhibitors Companies , Molecular Templates Inc , Akeso Inc , Key Companies , Chia Tai Tianqing Pharmaceutical Group Co Ltd , Competitive Landscape , Clinical Trials , Competitive Landscape Insight , Pipeline Insight , Competitive Landscape Report , Shanghai Henlius Biotech , Harbour Biomed , Alphamab Oncology , Molecular Templates ,

Alphamab Oncology's KN046 Trial Misses Endpoint

Alphamab Oncology (HK:9966) has released an update. Alphamab Oncology has announced that the Phase III clinical trial of KN046 for treating advance. ....

Alphamab Oncology ,

Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of HER3/TROP2 Bispecific ADC Drug JSKN016

SUZHOU, China, May 22, 2024 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I… ....

Hong Kong , China National Medical Products Administration , Alphamab Oncology , Main Board , Hong Kong Stock Exchange , Breakthrough Designation , China National Medical Products ,

Alphamab Oncology Presented the Dose-escalation Results from JSKN003 in Patients with Advanced/Metastatic Solid Tumors at AACR

Alphamab Oncology Presented the Dose-escalation Results from JSKN003 in Patients with Advanced/Metastatic Solid Tumors at AACR
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

Hong Kong , United States , Claire Beecroft , China National Medical Products Administration , American Association For Cancer Research Annual Meeting , Alphamab Oncology , American Association , Cancer Research Annual Meeting , Poster Section , Main Board , Hong Kong Stock Exchange , Breakthrough Designation , China National Medical Products ,

Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights

SUZHOU, China, March 29, 2024 /PRNewswire/ Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2023 and ....

Hong Kong , United States , Jiangsu Alphamab , Asia Pacific , Pharmaceuticals Inc , Chinese Pharmaceutical Innovative Enterprises , China National Medical Products Administration , Hong Kong Stock Exchange , Drug Administration , Bellberry Human Research Ethics Committee , Society For Immunotherapy Of Cancer , Chinese Pharmaceutical Listed Companies , European Society For Medical Oncology Congress , Nature Communications , American Association For Cancer Research , Alphamab Oncology , European Journal , Medical Oncology Congress , Cell Reports Medicine , Drug Evaluation , San Antonio Breast Cancer Symposium , Cancer Research , United States Food , Middle East , Independent States , Bellberry Human Research Ethics ,